Cargando…
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Parkinson’s disease (PD) is a devastating and highly prevalent neurodegenerative disease for which only symptomatic treatment is available. In order to develop a truly effective disease-modifying therapy, improvement of our current understanding of the molecular and cellular mechanisms underlying PD...
Autores principales: | Xicoy, Helena, Wieringa, Bé, Martens, Gerard J.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259880/ https://www.ncbi.nlm.nih.gov/pubmed/28118852 http://dx.doi.org/10.1186/s13024-017-0149-0 |
Ejemplares similares
-
Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2019) -
The Role of Lipids in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2019) -
Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2020) -
Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson’s disease
por: Krishna, Abhimanyu, et al.
Publicado: (2014) -
On the cytotoxicity of HCR-NTPase in the neuroblastoma cell line SH-SY5Y
por: Pasdziernik, Markus, et al.
Publicado: (2009)